Lexicon Pharmaceuticals reported $-30278000 in Operating Profit for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbott ABT:US USD 1.33B 442M
Acadia Pharmaceuticals ACAD:US USD -46063000 15.2M
Acorda Therapeutics ACOR:US USD 27.41M 32.4M
Agios Pharmaceuticals AGIO:US USD 28.68M 115.33M
Akebia Therapeutics AKBA:US USD -6350000 42.73M
Alnylam Pharmaceuticals ALNY:US USD -188614000 146.01M
AstraZeneca AZN:LN USD 1.09B 151M
Biomarin Pharmaceutical BMRN:US USD -24500000 22.08M
Bluebird Bio BLUE:US USD -84781000 22.62M
Clovis Oncology CLVS:US USD -44235000 15.15M
Coherus Biosciences CHRS:US USD -51493000 28.96M
Eli Lilly And LLY:US USD 1.84B 159.9M
Esperion Therapeutics ESPR:US USD -42513000 890K
Halozyme Therapeutics HALO:US USD 74.51M 6.07M
Illumina ILMN:US USD -127000000 3.53B
Insmed INSM:US USD -151475000 23.78M
Intercept Pharmaceuticals ICPT:US USD -18024000 83.88M
Ironwood Pharmaceuticals IRWD:US USD 68.36M 110K
Johnson & Johnson JNJ:US USD 4.2B 1.62B
Lexicon Pharmaceuticals LXRX:US USD -30278000 7.18M
Macrogenics MGNX:US USD 11.98M 36.94M
Mannkind MNKD:US USD -12790000 3.18M
Merk MRK:US USD 3.51B 505M
Moderna Inc MRNA:US USD 1.58B 414M
Novartis NOVN:VX USD 1.95B 219M
Ptc Therapeutics PTCT:US USD -200341000 132.15M
Puma Biotechnology PBYI:US USD -2348000 4.72M
Sarepta Therapeutics SRPT:US USD -109408000 147.39M
Thermo Fisher Scientific TMO:US USD 1.86B 151M
Ultragenyx Pharmaceutical RARE:US USD -145628000 79.44M
United Therapeutics UTHR:US USD 175.6M 138.7M
Vanda Pharmaceuticals VNDA:US USD 6.63M 2.72M